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Cell-mediated  immunity  (CMI)  1 has  been  shown  in  experimental  animal 
models  to play  a  major  role in  resistance  against  many of the opportunistic 
pathogens  producing  disease  in  immunosuppressed  patients  (1).  Although 
monocytes and  macrophages have  been  shown  to  be  the major  effector cells 
of CMI against many of these pathogens in animals,  relatively little is known 
of the microbicidal  capacity of human monocytes and macrophages for these 
organisms.  In addition  to the problem  of infection in the immunosuppressed 
host,  the  concept  of  the  monocyte  derivation  of  macrophages  (2)  and  the 
development  of better  techniques  for human white  blood cell  separation  and 
in vitro  culture have been instrumental  in providing the impetus for investi- 
gations  into  the  microbicidal  capacities  of  human  macrophages  (3-12).  We 
chose to study the effect of human macrophages on the obligate intracellular 
protozoan Toxoplasma gondii because  this  organism is  an increasing  cause of 
morbidity and mortality in immunosuppressed patients  and because CMI has 
been  demonstrated  to play a  major role in host defense  against  this  parasite 
in experimental  animal models  (13-17). 
Materials and Methods 
Antibody Deterraination.--The Sabin-Feldman dye test  (DT) was performed as described 
by Frenkel and Jacobs (18) and the titer is reported as the initial dilution of the serum. 
Volunteers.--All volunteers were in good health and on no medications. Their ages ranged 
from 18 to 45 years and all were males. Individuals with titers of less than 1:2 were considered 
to be DT negative. Those positive in the DT were known to have chronic (latent) toxoplasmosis 
with stable titers  ranging from 1:32 to 1:512. 
Macrophage Cultures.--lO0-150 ml of heparinized  (10 U/ml) peripheral venous blood was 
drawn from each of 12 volunteers  (8 were DT negative, 4 were DT positive). Mononuclear 
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cells were obtained as previously described  (19). The cells were suspended in tissue culture 
medium 199 (M199,  Grand Island Biological Co., Grand Island, N. Y.) containing antibiotics 
(100 U penicillin/ml, 100 #g streptomydn/ml) and 40% autologous human serum (M199 + 
40% AS). The total number of mononuclear cells (monocytes and lymphocytes) was determined 
by counting in a hemacytometer. The proportion of mononuclear cells that were monocytes was 
determined as previously described (19) and ranged from 15-30%. The remainder of the cells 
were lymphocytes with rare  (<0.5%)  contamination  by grunuiocytes. More than 98%  of 
these cells were viable as determined by the exdusion of 1.5% trypan blue dye. 
Standard  sized Leighton tubes  (16  X  125 ram)  containing glass cover slips were seeded 
with mononuclear cells in 0.5 ml M199 +  40% AS. Each 0.5 ml contained 1 X  10  6 monocytes. 
After the monocytes were allowed to adhere to the cover slips for 2-4 h at 37°C in an atmosphere 
containing 5% CO2, the supernate was aspirated and the cell monolayer washed twice with 
Hanks' balanced salt solution (HBSS) to remove nonadherent cells. Vigorous washing was not 
carried out, so as to maintain integrity of the monolayer. The monolayers were reincubated 
with 2 ml of fresh M199 +  40% AS and the medium was changed every 3 days thereafter 
until the cells were utilized in experiments. After incubation for 5-8 days, the monocytes de- 
veloped the morphologic criteria for macrophages (20). In all monolayers, a few lymphocytes 
remained adherent to the cover slips, but accounted for less than 1% of the mononuclear cells. 
Viability of monolayers was considered satisfactory if  >90% of the macrophages excluded 
trypan blue dye and/or actively incorporated tritium-labeled uridine ([3H]UdR, 28 Ci/mmol 
sp act, New England Nuclear Corp., Boston, Mass.) as determined by autoradiography. When 
tested on days 5-10 of incubation, 50-90% of the macrophages in any given monolayer phago- 
cytized heat-killed Candida albicans. 
Preparation of  Toxoplasma.--Purified  preparations  of Toxoplasma  trophozoites  of  the 
RH strain were obtained from the peritoneal fluid of 2-day infected mice as previously de- 
scribed  (21, 22).  The organisms were suspended in cold (4°C)  M199 containing 40% heat- 
inactivated homologous human plasma (M199  +  40% I-1P) and counted in a hemacytometer. 
(The human plasma was obtained from a  single individual whose plasma was known to be 
negative in the DT when tested undiluted and not heat inactivated, indicating total lack of 
measurable Toxoplasma neutralizing antibody.  The plasma  was  heat inactivated  at  56°C 
for 45 min to remove the "accessory factor" necessary for neutralization of Toxoplasma by 
antibody,  [23, 24]). The suspension  of organisms was brought  to room temperature  at the 
time of challenge of the monolayers. 1 million organisms prepared in this manner killed 100% 
of mice within 6 days following intraperitoneal injection. 
The ability of the extracelluiar organisms in the challenge inoculum to incorporate [aH]UdR 
into parasite RNA was assessed  by the use of autoradiography  (21). At the same time the 
parasites were being placed on macrophage monolayers, 20 X  106 organisms from the same 
challenge inoculum were suspended in 2 ml of M199 containing 40% DT negative, heat in- 
activated, dialyzed AB serum (M199  +  40% DS) and 20/~Ci[aH]UdR. This suspension was 
then continuously agitated at 37°C and after 30-60 min, 0.5-ml aliquots were removed for 
cytocentrifuge preparations  (Shandon-Elliot cytocentrifuge, Shandon Southern Instruments, 
Inc., Sewickley,  Pa.).  Autoradiography was performed after fixation of the preparations in 
0.4% amino-acridine hydrochloride in 50% ethanol (17).  Grain counts were performed on a 
minimum of 500 Toxoplasma. 
Infection of Macrophages.--Before infection, medium from each monolayer was replaced 
with fresh M199 +  40% AS containing 0.01 M uridine (UdR, Caibiochem, San Diego, Calif.). 
After reincubation for 4-6 h, cultures were washed with HBSS, decanted, and then infected 
with 5  X  106 Toxoplasma trophozoites in 0.5 ml of M199 +  40% HP. 30 mins later (zero 
time) the cultures were washed with HBSS to remove extracelhilar organisms, fresh M199 + 
40% AS was added, and the monolayers reincubated. At zero time and at various intervals 
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5/zCi of [3H]UdR was added to the cultures. After a 30-60 min pulse cover slips were removed, 
rinsed in isotonic saline, and processed for autoradiography. Duplicate cover slips were prepared 
for all time intervals. Grain counts were performed on the intracellular organisms in phagocytic 
vacuoles in a minimum of 200 macrophages per slide. 
In evaluation of autoradiographs, close agreement was noted between the results of grain 
counts  over intracellular  Toxoplasma  obtained  on  duplicate  slides.  The  vast  majority  of 
Toxoplasma were either labeled with a grain count  >__5 or <2  (mostly unlabeled); few were 
labeled with 2-4 grains. Using a grain count of > 5 clearly distinguished morphologically intact 
organisms from those which had ill-defined  borders and the unstained cytoplasm characteristic 
of dead organisms (23) (Fig.  1 a, b). However, some Toxoplasma which were not labeled with 
[zH]UdR had  the clear staining qualities of those which had  >5 grains  (Fig.  1 c).  For this 
reason,  staining  qualities alone were not considered a  satisfactory criterion of viability of 
Toxoplasma (17). Also, organisms with >5 grains were easily distinguished from background. 
Greater than 95% of organisms which had multiplied intracellularly and formed pairs, tetrads, 
or rosettes had grain counts of  >5 per organism.  By using the criterion of  >5 grains per 
organism to define viable Toxoplasma the population of metabolically active organisms cap- 
able of intracellular replication was readily identified. 
"Activation" of Macrophages.--Monolayers prepared as described above, with the excep- 
tion that the nonadherent cells (mainly lymphocytes)  were not washed off the  cover slips, 
were incubated  with  or without  antigen for 6-8 days  without changing  the medium. The 
antigens  were  10  #g/ml  Streptokinase-Streptodornase  (SK-SD,  kindly  supplied  by  Dr. 
W. M. Sweeney,  Lederle Laboratories, Pearl River, N. Y.) prepared as previously described 
(25) or 10-15 ~zg/ml Toxoplasma lysate antigen (TLA) (26). Separate experiments had  estab- 
lished that these concentrations of antigen and  the time period of macrophage exposure to 
antigen used  (6-8  days)  resulted in satisfactory  macrophage  monolayers with evidence of 
antigen stimulation as determined by morphologic criteria (20, 27) and lymphocyte transforma- 
tion. 
Lymphocyte Transformation.--In all activation experiments, nonadherent cells were removed 
just before the addition of the UdR to the monolayer. The nonadherent cells from each group 
of Leighton tubes which had been cultured with or without antigen were pooled.  From each 
group, four plastic tubes (16  X  125 mm, Falcon Plastics, Div. of BioQuest, Oxnard,  Calif.) 
each containing 1 X  106 mononuclear cells suspended in 2 ml of M199 q- 40% AS with 2 
/zCi tritium-labeled thymidine ([ZH]TdR, 6.0 Ci/mmol sp act, New England Nuclear Corp.) 
were prepared.  After incubation for 24 h,  three tubes were used for measuring lymphocyte 
transformation as previously described  (26). The degree of lymphocyte transformation was 
determined by calculation of the ratio A:C of uptake of [3H]TdR  (cpm)  obtained in mono- 
nuclear cell cultures incubated in the presence (a)  and the absence  (c) of antigen. Cytocen- 
trifuge preparations for autoradiography were made from the fourth tube. The mononuclear 
ceils from tubes with or without antigen had comparable viability (>900/0)  as determined by 
exclusion of trypan blue dye. 
RESULTS 
Effect of Macrophages from DT-Negative and DT-Positive Subjects on  Toxo- 
plasma.--After  challenge with Toxoplasma for 30 min  (zero  time),  a  mean  of 
55 %  (range  20-92 %)  of the macrophages  were infected by  at  least one orga- 
nism  (radiolabeled  or  unlabeled).  Many  were  multiply  infected;  the  mean 
number of Toxoplasma per infected cell was 3.1  (range 1.7-7.8). 
Eight  experiments  were  performed  with  macrophages  from  DT-negative 
individuals  and  four  with  macrophages  from  DT-positive  individuals.  A Fro.  1.  Variability in appearance  of Toxoplasma in autoradiographs  of Toxoplasma-in- 
fected monolayers of normal human monocyte-derived macrophages.  (a)  1 h  after zero time. 
Toxoplasma with > 5 grains (arrow). Morphology and stainingcharacteristics of such organisms 
were those associated with viable Toxoplasma.  X  1,500. (b)  1 h  after zero time. Nonlabeled 
Toxoplasma  (arrow).  Morphologically  intact  organisms  but  with  ill-defined  borders  and 
lightly stained cytoplasm characteristic of dead organisms (23).  (c)  1 h after zero time. Toxo- 
plasma pretreated with antibody in the absence of accessory factor (arrow).  In some instances, 
as shown here, the organisms appeared to be viable by morphologic and staining characteristics 
but failed to incorporate [sH]UdR.  Such organisms subsequently underwent dissolution. For 
this reason, staining qualities alone were not considered a satisfactory criterion of viability of 
Toxoplasma (17). (d) 4 h  after zero time. Fragments of Toxoplasma (arrows)  demonstrating 
dissolution  of nonlabeled  organisms.  X  1,200. 
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representative example of the results is shown in Fig. 2. Over a  20-h  period, 
the number of viable intracellular Toxoplasma in macrophages obtained from 
DT-negative and DT-positive individuals increased (Fig. 2 a, d), although the 
percent of cells infected with viable Toxoplasma remained constant (Fig. 2 c). 
As shown in Fig. 2 b, the majority (>85%)  of Toxoplasma at 30 min and 90 
min after zero time were not labeled with ___5 grains per organism and almost 
all such organisms appeared to be dead as judged by staining characteristics 
(Fig. 1 b). With increasing time the percent of organisms with >5 grains in- 
creased to >90%. After 4-6 h, the total number of Toxoplasma labeled with 
<5 grains had greatly diminished (from >300 per  100 macrophages to  <10 
per 100 macrophages), indicating rapid dissolution of those parasites and such 
organisms were recognizable only as amorphous material or nuclear remnants 
within cytoplasmic vacuoles  (Fig.  1 d).  These results suggest that  the vast 
majority of organisms in the challenge inoculum were either dead before entry 
into the macrophages or were "attenuated" to such a  degree that they were 
unable to multiply intracellularly and died within a few hours of causes other 
than macrophage killing. Further evidence for this was obtained in experiments 
performed to determine the percent of organisms in the challenge inoculum 
which were metabolically active such that they were incorporating [~H]UdR. 
Autoradiographs of the challenge inoculum of each experiment revealed that 
from 8-20 % of the organisms were labeled with ~ 5 grains, closely approximat- 
ing the percent of intracellular organisms that had > 5 grains at 30-90 rain after 
zero  time. In contrast,  greater  than 85 %  of the organisms in  the challenge 
inoculum excluded trypan blue  dye indicating that  dye exclusion is not as 
sensitive  as  [~H]UdR  uptake  as  an  indicator of those organisms capable  of 
intracellular replication.  That  greater  than  80%  of the  Toxoplasma in  the 
challenge inoculum were unable to incorporate [3H]UdR can be attributed to 
the time consuming method of preparing a purified suspension of trophozoites, 
as trophozoites rapidly lose viability in an extracellular environment (28). 
Macrophages obtained from either DT-negative or ])T-positive individuals 
demonstrated no difference in their effect on Toxoplasma; this was true if the 
incubation  medium  added  to  the  monolayers after  parasite  challenge  con- 
tained ])T-negative or DT-positive  serum.  The photomicrographs in  Fig. 3 
are representative of the results of these experiments. 
Effect of Macrophages on Toxoplasma  Exposed to Antibody before Infection.- 
These experiments were performed to evaluate whether Toxoplasma exposed 
to antibody in the absence of accessory factor are more readily killed by normal 
macrophages.  Just  before  macrophage  challenge,  the  organisms  were  incu- 
bated  at 37°C for 30 min in medium containing 40%  heat-inactivated ])T- 
positive human serum (DT titers ranged from 1:32-1:4,096).  Control macro- 
phage monolayers prepared from the same subject were challenged simultane- 
ously with a Toxoplasma inoculum which had been similarly preincubated in 
medium containing 40 % heat-inactivated DT-negative human serum. Follow- 12C 
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FIO. 2.  Effect on Toxoplasma of human monocyte-derived macrophages from DT-negadve 
(0)  and  DT-posldve  (O)  subjects.  (a)  Total number  of viable intracellular Toxoplasma 
(defined as organisms labeled with >_5 grains, see text) per 100 macrophages.  (b)  Percent of 
intracellular Toxoplasma which were viable. (c) Percent of macrophages infected with viable 
Toxoplasma. (~) Number of viable intraceUular Toxoplasma per 100 infected macrophages. It 
should be emphasized that the denominator is the number of macrophages infected with any 
Toxoplasma  (labeled  or  unlabeled).  This  demonstrates  the  intracellular  multiplication  of 
Toxoplasma that has occurred. 
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ing parasite challenge, the macrophage monolayers were handled as usual ex- 
cept that the fresh medium added was the same as used for preincubation of 
the challenge inoculum. Results of autoradiography of organisms in the chal- 
lenge  inoculum  and  of  mouse inoculation experiments  did not reveal  a  dif- 
ference in viability between the antibody-treated and control organisms. 
A  representative  result  of six  separate  experiments  is  shown in Fig.  4.  By 
20 h, a marked increase was noted in the number of viable, intracellular  Toxo- 
plasma  in  the  control  monolayers,  whereas  no  such  increase  was  noted  in 
macrophages infected with organisms which had been treated with antibody. 
By 40 h, the control monolayers had been destroyed  by Toxoplasma. In con- 
trast,  monolayers infected with  antibody-treated Toxoplasma were relatively 
intact  at  this  time period.  That pretreatment  of trophozoites with  antibody 
did not result in the intracellular killing of all Toxoplasma was evidenced by 
the  fact  that  small  numbers  of  macrophages  with  radiolabeled  replicating 
Toxoplasma were demonstrable at 20-40 h. 
Effect  of Activated  Macrophages on  Toxoplasma.--Macrophages  incubated 
with  autologous lymphocytes in the presence of SK-SD or TLA (in  the case 
of DT-positive individuals)  are referred to below as  stimulated macrophages 
(SM). Macrophages incubated with autologous lymphocytes in the absence of 
antigen are referred to as control macrophages (CM). In the SM monolayers 
there was an increased number of giant multinucleated cells and glass adherent 
lymphocytes, markedly increased cytoplasmic bridging from macrophages to 
other macrophages and lymphocytes, increased numbers of mitotic figures,  and 
particularly prominent  clumping of cells  into  "immunological islands"  (20), 
consisting of a  central  core of one or more macrophages around which were 
clustered both unlabeled small  lymphocytes and larger  transformed lympho- 
cytes with heavy uptake of [3H]TdR (Fig.  5 a-c).  The adherence of lympho- 
cytes to  glass  and  to macrophages in  the presence of antigen  accounted for 
our inability to prepare monolayers totally devoid of lymphocytes. Repeated 
washing failed to remove all  the lymphocytes and the presence of even small 
numbers of lymphocytes resulted  in  some degree of clustering when  antigen 
was added to the cultures. We were therefore unable to accurately assess  the 
FIG.  3.  Giemsa-stained preparations of  normal human monocyte-derived macrophages 
infected with Toxoplasma in vitro. (a) 1 h after zero time. A single Toxoplasma is seen within 
a vacuole  in the cytoplasm. (b) 8 h after zero time. The Toxoplasma have undergone a single 
division here depicted as three separate pairs. The third pair is to the right of the nucleus. (c) 
12 h after zero time. The Toxoplasma have undergone a second division and four organisms 
can be seen within each of the two vacuoles. (d) 20 h after zero time. Multiple divisions have 
occurred resulting in rosette formation (arrow). (e) 40 h after zero time. Macrophages  infected 
with Toxoplasma appear to be undergoing cell lysis with release of the organisms. (f) 40 h 
after zero time. Cytocentrifuge  preparation of supernate of infected macrophage monolayer. 
Cystlike structures (arrow) can be seen within cytoplasmic vacuoles in some macrophages. 
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FIO. 4. Effect of normal human monocyte-derived  macrophages on Toxoplasma  which had 
been exposed to anti-Toxoplasma  antibody before infection. (e), macrophages infected with 
Toxoplasma which had not been exposed to antibody; (I), macrophages  infected with Toxo- 
plasma which had been exposed to antibody. 
role of the lymphocyte in this in vitro model, since we could not determine the 
effect of antigen stimulation alone on monolayers of macrophages totally free 
of lymphocytes. 
Evidence  for  antigen  stimulation  of  the  lymphocytes was  the  increased 
uptake of [~H]TdR (determined both by scintillation counting and  autoradi- 
ography) by nonadherent cells from SM cultures as compared to CM cultures. 
The mean ratio A: C of [3H]TdR uptake in cell cultures stimulated with SK-SD 
was 4.0  (range 2.3-7.4)  and in cell cultures prepared from DT-positive indi- 
viduals  and  stimulated  with  TLA was  5.7  (range  3.7-9.2).  However, when 
macrophages from DT-negative individuals were incubated  with  autologous 
lymphocytes and TLA, there was no evidence of antigen stimulation,  either 
morphologically or by lymphocyte transformation. Autoradiographs revealed 
blastogenic transformation (Fig. 5 d) of 8-23 %  (mean 14.5 %) of lymphocytes 
from antigen-stimulated cultures (either SK-SD or TLA) compared to  < 2 % 
(mean  1.6%)  in  control cultures. 
Six experiments with SK-SD SM were performed and the results were similar 
in each. As shown in Fig. 6, the SM monolayer from a DT-negative individual FIG. 5.  Morphologic changes observed in macrophage monolayers cultured in the presence 
of sensitized lymphocytes and antigen. (a) I h after zero time. Multinucleated giant cell which 
has phagocytized a macrophage containing a single Toxoplasma (arrow). The Toxoplasma is 
not labeled by [3H]UdR and appears to be undergoing dissolution.  (b) Monolayer labeled with 
[3H]TdR. Note the clustering of macrophages  (arrow, upper right), transformed lymphocytes 
incorporating [3H]Tdl~ (arrow, lower left)~ and nontransformed unlabeled lymphocytes (arrow, 
lower right) into an "immunologic island" (20). (c) Multinucleated giant cell and lymphoblast 
which has incorporated [3H]TdR, demonstrating characteristic juxtaposition of lymphocytes 
and macrophages in antigen stimulated monolayers.  (d) Autoradiography of a cytocentrifuge 
preparation of supernatant ceils from a macrophage monolayer which had been incubated for 
6 days in the presence  of sensitized  lymphocytes and antigen. Just before infection of the 
monolayer,  the supernatant cells were removed and incubated for 20 h with [3H]TdR. Note 
lymphoblasts which have incorporated [3H]TdP, in comparison  to the nontransformed lym- 
phocyte (arrow).  X  1,200. 
1163 FIo.  6.  Resistance  of  monolayers  of  SK-SD  stimulated  and  control human monocyte- 
derived macrophages to infection with Toxoplasma.  (a) Control macrophages 1 h  after zero 
time.  (b) Control macrophages 70 h  after zero time. There is almost complete destruction of 
the monolayer.  (c) Stimulated macrophages 1 h after zero time.  (d)  Stimulated macrophages 
70 h after zero time. There is remarkable sparing of the monolayer. X  120. 
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showed marked resistance to necrotization by Toxoplasma whereas the CM 
monolayer was almost completely destroyed by 70 h  after parasite challenge. 
This difference in resistance was demonstrable as early as 20 h after zero time. 
A representative example of the quantitative results of these experiments is 
shown in Fig. 7.  By 20 h,  the number of viable intracellular Toxoplasma in 
CM had increased rapidly; in marked contrast, the number of viable organisms 
in SM had declined (Fig. 7 a, d).  After 20 h, there was evidence of multipli- 
cation of some intracellular Toxoplasma in SM. In SM,  at 8 and 20 h  (Fig. 
7 b), the great majority (>85%)  of organisms had <5 grains (most were un- 
labeled) and were only identifiable as poorly stained fragments inside a cyto- 
plasmic vacuole (Fig. 8 a). During the same time interval, > 95 % of organisms 
in CM incorporated >5 grains (Fig. 7 b), had normal morphology and staining 
characteristics, and most had multiplied (Fig. 8 b). The percent of CM infected 
with  viable  Toxoplasma  remained  constant until  40  h  and  then  increased 
rapidly, suggesting that there was disruption of parasitized cells followed by 
invasion of  uninfected macrophages  and this was confirmed by microscopic 
observation. The percent of SM infected with viable Toxoplasma decreased 
over the first 20 h and then increased gradually (Fig. 7 c). 
The mean percent of cells infected with Toxoplasma and mean number of 
Toxoplasma per infected cell were generally greater in CM than SM monolayers. 
At 1 h, a mean of 56% (range 24--85%) of CM were infected with Toxoplasma 
(labeled or unlabeled) with a  mean of 3.0  (range  1.7-5.3)  organisms per in- 
fected cell;  the  corresponding figures for  SM  monolayers were  44%  (range 
32-78 %) and 2.3 (range 1.7-4.0). (These differences between CM and SM were 
not statistically significant [P >  0.2, Student's t test]). The differences observed 
could not be attributed to any difference in the number of viable organisms in 
the challenge inoculum for CM and SM since both were infected simultaneously 
with the same Toxoplasma preparation. The differences were most likely the 
result of the inhibition of [aH]UdR uptake by Toxoplasma and the more rapid 
dissolution of the organisms within SM during the first hour after initial in- 
fection, as was also observed in the mouse model (17).  The clustering of cells 
noted in SM monolayers may also have been a contributing factor. 
Three experiments were performed in which macrophages from DT-positive 
individuals were incubated with  autologous lymphocytes and TLA. Results 
were similar to those observed in monolayers of SK-SD SM. However, when 
macrophages from DT-negative individuals were incubated with  autologous 
lymphocytes and TLA these macrophages were similar to CM in their effect 
on Toxoplasma  (i.e.,  there was  no  evidence of monolayer resistance  to  nor 
macrophage killing of Toxoplasma). 
DISCUSSION 
The  results  described  above  demonstrate  that  normal  human monocyte- 
derived macrophages cultured in vitro  are incapable of significant killing or 1166  EFFECT  OF  HUMAN  ]~ACROPI-IAGES  ON  TOXOPI-,ASMA  GO.NDII 
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Fro. 7.  Effect of SK-SD stimulated (A) and control (0) human monocyte-derived macro- 
phages on Toxoplasma as determined by autoradiography. (a) Total number of viable intra- 
cellular Toxoplasma per 100 macrophages. (b) Percent of intracellular Toxoplasma which were 
viable. (c) Percent of macrophages infected with viable Toxoplasma.  (d)  Number of  viable 
intracellular Toxoplasma per  100 infected macrophages. The decrease in number of viable 
intracellular Toxoplasma in CM between 40 h  and 70 h  represents the lysis of macrophages 
by the parasites and subsequent invasion of uninfected macrophages. FIG. 8.  Observations in monolayers of SK-SD stimulated and control human macrophages 
from  a  single experiment.  (a)  8  h  after  zero  time.  Macrophage  in  stimulated  monolayer. 
Toxoplasma in vacuoles (arrows)  appear fragmented and are undergoing dissolution. X  1,200. 
(b) 20 h after zero time. Macrophage in control monolayer. Toxoplasma have formed a rosette 
(arrow)  and have incorporated [aH]UdR.  (c)  1 h  after zero time. Radiolabeled and nonradio- 
labeled Toxoplasma in a single nonactivated macrophage. The nonlabeled organisms (arrows) 
are altered in morphology and staining characteristics, indicative of early dissolution, com- 
pared  to labeled organisms.  X  1,500. 
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inhibition  of  replication  of  Toxoplasma.  While  normal  human  monocyte- 
derived macrophages were apparently incapable of killing Toxoplasma, they 
were capable of the intracellular digestion of attenuated or dead organisms. 
These results in human macrophages are similar to our previous observation 
of the survival and multiplication of Toxoplasma in peritoneal macrophages of 
normal mice (17).  Jones and Hirsch (29),  utilizing data derived from electron 
microscopy studies, concluded that the inability of the peritoneal macrophages 
of normal mice to kill Toxoplasma was linked to the lack of fusion of lysosomal 
granules with phagosomes containing viable Toxoplasma. They considered that 
this was due to some property of the parasite rather than of the macrophage, 
since single macrophages were noted in which dead Toxoplasma undergoing di- 
gestion and viable organisms existed side by side in separate vacuoles. Similarly, 
we frequently observed human macrophages in which Toxoplasma that had 
incorporated  [3H]UdR  and  nonlabeled  fragmented  Toxoplasma  apparently 
undergoing digestion were present in the same cell  (Fig. 8 c). 
In  the present  study, macrophages  from Toxoplasma-infected individuals 
did not differ from macrophages from noninfected individuals in their effect 
on  Toxoplasma.  In  contrast,  peritoneal  macrophages  from  Toxoplasma-in- 
fected mice inhibit or kill Toxoplasma whereas macrophages from normal mice 
support  the growth of the organism  (17).  While our in vitro results did not 
reveal  a  difference between macrophages from normal individuals and those 
from humans with toxoplasmosis, this may not necessarily reflect the situation 
as it exists in vivo. The macrophages employed in the present study were not 
obtained directly from the host,  as was true for the mouse model, but were 
derived from monocytes by long-term culture in vitro. 
In 1965, Stadtsbaeder (3) described results of studies of the effect of normal 
human leukocytes cultured in vitro on Toxoplasma and concluded that human 
monocytes support  the intracellular multiplication of Toxoplasma. Although 
it is unclear from his publication whether the observations were made on early 
or late monocyte cultures,  it  appears  that  Stadtsbaeder's  studies were with 
monocyte-derived macrophages  and  that  his  findings were  similar  to  ours. 
Abell and Holland (30) described viable Toxoplasma trophozoites in the cyto- 
plasm of mononuclear cells in the bone marrow of  a  child  with  acute  toxo- 
plasmosis,  acquired  during a  drug-induced remission of acute lymphoblastic 
leukemia. Although this patient's mononuclear cells may have been defective 
in microbicidal capacity due to the underlying disorder, the chemotherapeutic 
agent used, or both, this case may represent an in vivo correlate of the in vitro 
findings of Stadtsbaeder and the present study. 
Although  relatively little  is  known  about  the  microbicidal  capacities  of 
human monocyte-derived macrophages  against facultative or obligate intra- 
cellular organisms, some data are available on the ability of these cells to handle 
Listeria  monocytogenes,  Mycobacterium  leprae, Cryptoeoecus  neoformans,  and 
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from normal subjects have been reported to be capable of killing L. monocyto- 
genes (4) but not M. leprae  (10), C. neoformans (8), and R. mooseri  (11), which 
survive and multiply within these cells.  Diamond and Bennett (8)  suggested 
that macrophages might contribute to the extension and dissemination of cryp- 
tococci by providing an intracellular shelter for the organism with a favorable 
environment for growth. Such a means of dissemination may also be postulated 
for Toxoplasma since it has the ability to survive within the normal human 
macrophage. 
Lycke and his colleagues have shown that, even in the absence of accessory 
factor, antibody will have an effect on Toxoplasma in a tissue culture system 
in  vitro  (31). To gain information on the  effect of macrophages per  se,  we 
therefore considered it  necessary to perform studies  in  the  absence of con- 
ventional humoral antibody. Once Toxoplasma were intracellular, addition to 
the medium of antibody alone or antibody plus accessory factor had no demon- 
strable effect on the interaction of macrophages and Toxoplasma. However, 
exposure of Toxoplasma to antibody plus accessory factor before entry into 
macrophages resulted in rapid extracellular killing of the organisms (less than 
0.1%  of extracellular Toxoplasma which had been preincubated at 37°C  for 
30 min with antibody and accessory factor were viable) and any additional ef- 
fect macrophages may have had under these conditions could not be evaluated. 
Of interest was the observation that although no difference in viability could 
be  distinguished  between  extracellular Toxoplasma which  had  been  treated 
with heat-inactivated antiserum or with serum which contained no antibody, 
the former were inhibited or killed by normal human macrophages. This ob- 
servation is similar to that observed with R. mooseri which, when treated with 
human antiserum, were rendered susceptible to destruction within nonimmune 
human  monocyte-derived macrophages  in  vitro  (12).  The fact  that  not  all 
intracellular Toxoplasma which had been treated with heat-inactivated anti- 
serum were killed by macrophages might be explained by either a heterogenous 
population  of  infected  macrophages  (e.g.,  a  subpopulation  of  macrophages 
incapable of inhibiting or killing Toxoplasma), or the  method  used  for  pre- 
incubation of Toxoplasma with antiserum may not have resulted in adequate 
"preparation" for killing of all the organisms. The latter explanation appears 
most likely since even the  addition of accessory factor did not kill  100% of 
extracellular organisms with the preincubation method employed. In separate 
studies, we have observed that monolayers of normal human peripheral blood 
monocytes cultured for 2 h  are rapidly destroyed by Toxoplasma. However, 
pretreatment  of  Toxoplasma with  heat-inactivated  antiserum  markedly  in- 
hibited  the  cytocidal effect of the  organisms,  evidently due to inhibition or 
killing  of  antibody-coated  Toxoplasma  by  the  monocytes  (Anderson  and 
Remington, unpublished data). Whether cell-bound antibody may play a role 
in  ingestion  or  killing,  or  both,  by macrophages  from Toxoplasma-infected 
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present on the monocytes in vivo, it is unlikely we would have demonstrated 
any functional activity it may confer because of the prolonged time these cells 
were cultured in vitro before challenge. 
Since activated mouse peritoneal macrophages can inhibit or kill Toxoplasma 
(15-17) and since animal macrophages can be activated in vitro by sensitized 
lymphocytes cultured in  the presence of specific antigen to kill intracellular 
organisms  (32-36), we attempted to activate human macrophages in vitro by 
culturing them in the presence of sensitized lymphocytes and specific antigen. 
The activation by lymphocytes was shown to be antigen-specific and conferred 
upon normal human macrophages the capacity to destroy intracellular Toxo- 
plasma.  Killing, in contrast to mere inhibition of the organism,  was  demon- 
strated by the fact that viable organisms identified intracellularly at 1 h  after 
zero time either disappeared or could be identified only as fragments within a 
few  hours  thereafter.  In  addition  to  the  autoradiographs,  examination  of 
duplicate macrophage monolayers (taken at identical time interva]s from the 
same experiment) by phase microscopy revealed a  significant decrease in the 
number of live organisms during the first 4-20 h after zero time in macrophages 
which had been cultured in the presence of lymphocytes plus specific antigen 
but  could not be demonstrated in macrophages which had been cultured in 
the presence of lymphocytes without antigen. 
Of  interest  is  the  observation  that  monolayers of  SM  which  showed  re- 
markable resistance to necrotization by Toxoplasma and which inhibited the 
organism's replication and ultimately killed it, appeared to lose this resistance 
by 40 h  of infection. By that  time, an increased percentage of cells could be 
seen to be infected with viable organisms that were actively multiplying. This 
loss of resistance was also observed in the Listeria model (15) in which mono- 
layers  of  activated  macrophages  which  were  initially  remarkably  protected 
against destruction by Listeria were ultimately destroyed due to overwhelm- 
ing reinvasion by organisms released from destroyed cells.  A possible explana- 
tion is that macrophages lose their "activation" during the course of the 70-h 
time period examined. Despite the increase in the number of SM infected with 
viable Toxoplasma observed after 40 h, allowing incubation to continue for an 
additional 30 h did not allow for replication and reinvasion comparable to that 
observed in CM. Another possible explanation is that not all macrophages in 
SM monolayers were activated. As is true for other models in which monolayers 
of  activated  macrophages  have  been  compared with  monolayers of normal 
macrophages, it is unclear as to what percent of the macrophages were actually 
activated. In the present study, the percent of macrophages that were activated 
can be approximated from the percent of SM infected with viable Toxoplasma 
at  1 h  compared with the percent at 8 h; the data from six separate experi- 
ments revealed that 70-80% of the SM infected with viable Toxoplasma were 
activated to kill Toxoplasma (i.e., 7.5 % of SM were infected with  viable  or- 
ganisms at 1 h and only 1.5 % had viable organisms at 8 h, suggesting that 80 % 
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number of viable Toxoplasma in SM appears  to decline during the initial 20 h 
of infection,  these results actually reflect  a  summation of destruction of or- 
ganisms by 70-80%  of the infected cells and replication  of organisms  in ap- 
proximately 20%  of the infected cells. The effect of the latter is not clearly 
seen in our graphed data since they account for so few of the total. 
Interestingly, Cline  noted that monocyte-derived macrophages  from sub- 
jects with active tuberculosis,  leprosy, or Hodgkin's disease had an enhanced 
capacity  to  kill  L.  monocytogenes  when  compared  with  monocyte-derived 
Inacrophages  from normal  subjects  (4). Despite  the  enhanced microbicidal 
capacity of macrophages  from patients with active leprosy for L. monocyto- 
genes, it appears  that M. leprae is able to survive  and multiply within mono- 
cyte-derived macrophages  from  patients  with  lepromatous  or  tuberculoid 
leprosy (6, 10). Godal et al. (37) demonstrated that human monocyte-derived 
macrophages  from patients with tuberculoid leprosy,  but not from patients 
with lepromatous leprosy,  were stimulated to undergo  morphologic  changes 
and proliferation  by exposure  to  specific antigen  (killed  M.  leprae) in  the 
presence  of  sensitized  lymphocytes. However,  the  microbicidal  capacity of 
these cells for M. leprae was not tested. Diamond and Bennett  (8) found no 
evidence of intracellular killing of C. neoformans by monocyte-derived macro- 
phages  of subjects with active cryptococcosis. They also noted that normal 
human monocyte-derived macrophages  which had been  activated in vitro by 
culturing them in the presence of autologous lymphocytes and SK-SD, crypto- 
coccin or viable  cryptococci,  did not acquire  a capacity to kill C. neoformans 
despite  the fact that they had an increased capacity to kill L. monocytogenes. 
Magliulo  et  al.  (9)  stated that human macrophages  obtained from subjects 
convalescing from tuberculosis could be activated in vitro by exposure to sen- 
sitized  lymphocytes and PPD.  Such macrophages  had increased  phagocytic 
and bactericidal  activity for Paracolonbacter compared to macrophages  ob- 
tained from normal subjects who did not react to tuberculin skin testing. The 
cells used in their study were obtained directly by a modification of Rebuck's 
skin-window technique.  Whether these  authors were indeed studying macro- 
phages  rather than monocytes is unclear from their report.  From the results 
obtained in each of the studies  described  above, it appears  that both normal 
and  activated human monocyte-derived macrophages  vary considerably  in 
their ability to handle different microorganisms. 
Although the relationship of the in vitro phenomena we and others have 
observed to the actual function of the human macrophage  in vivo remains to 
be elucidated, further efforts are warranted to attempt to define means whereby 
macrophages might be activated in vivo to kill or inhibit opportunistic patho- 
gens. 
SUMMARY 
Human  macrophages derived  from in  vitro  culture of  peripheral blood mono- 
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capacity for the obligate intracellular protozoan, Toxoplasma gondii. The effect 
of macrophages on intracellular Toxoplasma was evaluated morphologically by 
light and phase microscopy and by autoradiography. When macrophages from 
dye test  (DT)-negative or DT-positive individuals  were infected with  Toxo- 
plasma in  the presence of normal human serum,  the organisms were  able to 
multiply  intracellularly  with  resultant  destruction  of  the  monolayer.  Once 
organisms  were  intracellular,  the  presence  of  antibody-containing  serum  in 
the medium did not alter this inability of the macrophages to kill Toxoplasma. 
However, when Toxoplasma were incubated in the presence of heat-inactivated 
DT-positive serum  just  before infection  of the monolayers,  the  intracellular 
organisms  were  inhibited  or  killed  by normal  macrophages.  Attempts  were 
made to  activate macrophages in vitro to kill Toxoplasma. Macrophages in- 
cubated in the presence of sensitized lymphocytes and Streptokinase-Strepto- 
dornase  (SK-SD)  or  Toxoplasma  lysate  antigen  (TLA)  were  found  to  kill 
Toxoplasma when  compared  to  macrophages  incubated  in  the  presence  of 
lymphocytes from DT-negative  individuals  and  TLA  or lymphocytes alone. 
Thus,  in  vitro induction  of resistance  (both  specifically and nonspecifically) 
in human macrophages was accomplished by culturing these cells in the presence 
of specifically sensitized lymphocytes and antigen. These results suggest that, 
as in the mouse model,  activated human macrophages have the ability to in- 
hibit or kill intracellular Toxoplasma and that  these cells may be important 
as effector cells in cell-mediated immunity (CMI) to toxoplasmosis in man. 
Simeon C. Bautista provided valuable technical assistance. 
The opinions or assertions contained herein are the private ones of the authors and are not 
to be construed as official or reflecting the views of the Navy Department or the naval service 
at large. 
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